Snowdrift Parent Corp SCIP
The SEC does not publish structured financial data (XBRL) for Snowdrift Parent Corp, so there are no statement tables here.
This is common for foreign companies that trade over the counter and for filers that only submit documents.
Its filings are still listed below and on SEC EDGAR.
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Oct 30, 2026 | — |
| 424B3 | Prospectus | Oct 30, 2026 | — |
| S-4/A | Filing | Oct 29, 2026 | — |
| S-4/A | Filing | Oct 19, 2026 | — |
| S-4 | Registration for a merger or exchange | Sep 25, 2026 | — |
| DRS | Filing | Aug 12, 2026 | — |
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SCIP
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Tel Aviv
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 2147497
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.